Inventor profile of:

PETER SEBO

City:

PRAGUE

Country:

Czech Republic

Published Applications:

9

Last publication date:

2016-03-24

Top Assignees for applications by PETER SEBO

The entities that hold a legal rights for patent applications filed by inventor SEBO PETER:

Recent patent applications by SEBO PETER

PETER SEBO from PRAGUE, CZ has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-03-24
US20160083714A1
Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#2 | 2012-03-22
US20120071393A1
Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#3 | 2012-03-01
US20120052083A1
Chemistry; metallurgy

MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL

#4 | 2011-03-15
US11713708
-

Modified adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#5 | 2010-09-23
US20100239550A1
Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#6 | 2006-12-28
US20060292161A1
Chemistry; metallurgy

Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly)

#7 | 2006-07-20
US20060159697A1
Chemistry; metallurgy

Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#8 | 2006-02-07
US9907951
-

Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections

#9 | 2006-01-26
US20060019323A1
Physics

Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase

InventorID:

1481529 ⎘